Pazinaclone

ADVERTISEMENT

Identification

Molecular formula
C18H18N2O
CAS Number
103255-21-2
IUPAC Name
(9-methyl-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-2-yl)-(1-piperidyl)methanone
Molecular Weight
303.39g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2701g/cm3
Synonyms
BRN 4151017
Interesting facts

Interesting Facts about (9-methyl-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-2-yl)-(1-piperidyl)methanone

This complex compound, often referred to in the realm of synthetic chemistry, showcases the captivating world of organic compounds with intricate structures and potential applications. Here are some intriguing aspects that highlight its significance:

  • Structural Complexity: The compound contains a multifaceted tricyclic framework with diazatricyclic elements that capture the interest of researchers. The presence of piperidine and methanone groups further contributes to its diverse chemical interactions.
  • Potential Applications: Due to its unique structure, this compound may exhibit pharmacological properties, making it a candidate for further studies in drug development and medicinal chemistry.
  • Synthetic Chemistry: The synthesis of such compounds often involves elaborate methodologies, providing a rich interplay of reaction mechanisms that can be educational for chemistry students.
  • Research Interest: Compounds like these are frequently studied for their biological activity and ability to bind to specific receptors, making them valuable in the field of neuroscience and pharmacology.
  • Future Prospects: As scientists continue to explore compounds with similarities to this one, the potential for discovering new therapeutic agents remains a significant area of research and innovation.

Overall, (9-methyl-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-2-yl)-(1-piperidyl)methanone illustrates the beauty and complexity of chemical synthesis, presenting numerous opportunities for exploration within both academia and industry.

ADVERTISEMENT